These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9254089)

  • 1. Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment.
    Anderson GD; Lin YX; Berge C; Ojemann GA
    J Neurosurg; 1997 Aug; 87(2):252-6. PubMed ID: 9254089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative valproate administration does not increase blood loss during temporal lobectomy.
    Ward MM; Barbaro NM; Laxer KD; Rampil IJ
    Epilepsia; 1996 Jan; 37(1):98-101. PubMed ID: 8603633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of antiepileptic drug therapy on antioxidant enzyme activity and serum lipid peroxidation in young patients with epilepsy].
    Sołowiej E; Sobaniec W
    Neurol Neurochir Pol; 2003; 37(5):991-1003. PubMed ID: 15174247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of postoperative blood collection in brain tumor surgery under valproate medication.
    Psaras T; Will BE; Schoeber W; Rona S; Mittelbronn M; Honegger JB
    Zentralbl Neurochir; 2008 Nov; 69(4):165-9. PubMed ID: 18937170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
    Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH
    Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance.
    Varoglu AO; Yildirim A; Aygul R; Gundogdu OL; Sahin YN
    Clin Neuropharmacol; 2010 May; 33(3):155-7. PubMed ID: 20502135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate-associated coagulopathies are frequent and variable in children.
    Gerstner T; Teich M; Bell N; Longin E; Dempfle CE; Brand J; König S
    Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematological side effects of antiepileptic drug treatment in patients with epilepsy.
    Bachmann T; Bertheussen KH; Svalheim S; Rauchenzauner M; Luef G; Gjerstad L; Taubøll E
    Acta Neurol Scand Suppl; 2011; (191):23-7. PubMed ID: 21711253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
    Gidal B; Spencer N; Maly M; Pitterle M; Williams E; Collins M; Jones J
    Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsia; 2006 Dec; 47(12):2038-45. PubMed ID: 17201701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
    Chung S; Choi J; Hyun T; Rha Y; Bae C
    J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
    Tumay Y; Altun Y; Ekmekci K; Ozkul Y
    Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC; Diener W; Kutschke G; Schneble HJ; Korinthenberg R; Sutor AH
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W; Beydoun A
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
    Ugras M; Yakinci C
    Brain Dev; 2006 Oct; 28(9):549-53. PubMed ID: 16842952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antiepileptic drug monotherapy on one-carbon metabolism and DNA methylation in patients with epilepsy.
    Ni G; Qin J; Li H; Chen Z; Zhou Y; Fang Z; Chen Y; Zhou J; Huang M; Zhou L
    PLoS One; 2015; 10(4):e0125656. PubMed ID: 25915064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of administration of valproic acid on organ function and outcome in a canine lethal hemorrhagic shock model].
    Hu S; Hou JY; Li L; Yang MX; Sheng ZY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):471-4. PubMed ID: 21878170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.